Cross-source identity
National Provider Identifier 1376723684 as it appears in every federal dataset Fonteum holds. Each row is a distinct public source; the chip carries the source and the snapshot date behind that field — the record-level form of the source-provenanced graph.
| Federal source | Key | What it provides | Provenance |
|---|---|---|---|
| CMS Open Payments |
| NPI 1376723684 |
| 22 industry-payment records, 2024 |
| Source:CMS Open PaymentsSnapshot PY2024 |
| CMS Medicare Part D | NPI 1376723684 | 42 drugs prescribed, 2024 | Source:CMS Part DSnapshot DY2024 |
| Fonteum entity graph | entity 8d9b8242… | Canonical resolved node · 2 identifier(s) · 2 edge(s) | Source:Entity graphSnapshot 2026-06-11 |
Industry payments
Payments and transfers of value this clinician received from drug and device manufacturers, disclosed under the Physician Payments Sunshine Act. A payment is a disclosure, not a judgment.
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $911 | 2 |
| Food and Beverage | $699 | 19 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37 | 1 |
| Manufacturer | Amount | Records |
|---|---|---|
| Astrazeneca Uk Limited | $1,054 | 6 |
| Nevro Corp. | $269 | 3 |
| Astrazeneca Pharmaceuticals Lp | $143 |
Prescribing
Prescriptions written under Medicare Part D, aggregated by drug across the program. Totals reflect claims paid, not patients treated.
| Drug | Claims | Drug cost |
|---|---|---|
| Buprenorphine-Naloxone(Buprenorphine Hcl/Naloxone Hcl) | 154 | $19,721 |
| Suboxone(Buprenorphine Hcl/Naloxone Hcl) | 14 | $5,858 |
| Tizanidine Hcl | 51 | $1,215 |
| Albuterol Sulfate Hfa(Albuterol Sulfate) | 103 | $1,160 |
| Gabapentin | 107 | $856 |
Beneficiary counts below 11 are suppressed by CMS — the total shown is a lower bound.
Quality
CMS Quality Payment Program Merit-based Incentive Payment System (MIPS) final score, where this clinician participated. Absence of a score is not a quality signal — many clinicians report through a group or are exempt.
Enrollment & sanctions
Screening aid — re-confirm any match against the issuing list before acting. A clean result means no record was found in the federal OIG LEIE or the state Medicaid lists Fonteum currently holds (NY, OH, GA), not a guarantee that none exists elsewhere. Not a legal or credentialing certification.
Ownership & affiliations
One-hop relationships in the resolved entity graph — chain membership, ownership, and operation edges, each backed by a federal source row. Most individual clinicians carry none; edges populate for owners and organizations as the Lane D backfill runs.
| Relationship | Entity | Source |
|---|---|---|
| ← pays | Astrazeneca Uk Limited | cms_open_payments |
| ← pays | Abbvie Inc. (IL) | cms_open_payments |
| 4 |
| Becton, Dickinson And Company | $37 | 1 |
| Pfizer Inc. | $35 | 2 |